D. E. V. Wilman

Tumour inhibitory triazenes: Structural requirements for an active metabolite

T.A. Connors, Phyllis M. Goddard, Kanti Merai et al. · Biochemical Pharmacology · 1976 · 124 citations

Medicine, Organic Chemistry, Anti-cancer Agent +4

Alkylation of DNA by the Nitrogen Mustard Bis-(2-chloroethyl)methylamine

Martin R. Osborne, D. E. V. Wilman, P.D. Lawley · Chemical Research in Toxicology · 1995 · 95 citations

Phospholipid metabolites, prognosis and proliferation in human breast carcinoma

Timothy Smith, C. Bush, Charles Jameson et al. · NMR in Biomedicine · 1993 · 49 citations

Analogs of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents

Chui Sheung Leung, Martin Rowlands, Michael Jarman et al. · Journal of Medicinal Chemistry · 1987 · 30 citations · Full text

Medicinal Chemistry, Biochemistry, Octyl Derivatives +13

Cytotoxic Agents Designed To Be Selective for Liver Cancer2

Agussalim Bukhari, T.A. Connors, Aedin M. Gilsenan et al. · JNCI Journal of the National Cancer Institute · 1973 · 29 citations

Biochemistry, Medicine, Liver Physiology +12